FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Wednesday

 

New drug for treatment of MS developed in Russia













A new drug for the treatment of MS has recently been developed in Russia, according to an official spokesman for Veronika Skvortsova, Russia’s Minister of Health, reports The Pharma Letter’s local correspondent.

It is reported that the new drug, will be produced by Pharmasyntez, one of Russia’s leading drugmakers in cooperation with the Russian Institute of Bioorganic Chemistry, is currently the subject of clinical studies and will appear on the market after 2020.

Details of the new MS drug were not revealed, but back in April 2016 public records showed that Pharmasyntez had reported safety and efficacy data from a Phase IIa trial of Xemys, a CD antigen modulator, for the treatment of MS.

According to the Ministry of Health, the number of patients with MS in Russia is constantly growing.

Currently main available MS treatment is Copaxone

According to Russian scientists, currently there are only few drugs for the treatment of MS which are presented in the Russian market, the most important of which is Copaxone (glatiramer acetate) from Israel’s Teva Pharmaceutical Industries (NYSE: TEVA).In addition to Copaxone, there are also several generics of the drug, which are imported to Russia from abroad.

According to Alexander Gabibov, the professor of the Russian Institute of Bioorganic Chemistry, the recently developed drug involves the use of more specific therapy, when peptide fragments of myelin basic protein are integrated into liposomes.

It is planned that the new drug will be significantly cheaper than Copaxone and its other foreign analogues, the cost of treatment by which reaches thousands of dollars.  

According to data of the Russian Ministry of Health, in 2016 there were 72,767 people with MS registered in Russia, and the number of patients, suffering from this disease is steadily growing.

In the meantime, according to Professor Igor Stolyarov, head of the laboratory of neuroimmunology of the Center for MS of the Russian N P Bekhtereva Institute of Human Brain, the first drugs from the disease appeared about 30 years ago, after which the disease has started to be diagnosed with MRI.

Story Source: The above story is based on materials provided by THEPHARMALETTER
Note: Materials may be edited for content and length


Go to Newer News Go to Older News